Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFMW) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Sunshine Biopharma (SBFMW) over the last 14 years, with Q3 2025 value amounting to -$735840.0.

  • Sunshine Biopharma's Free Cash Flow rose 6072.55% to -$735840.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.4 million, marking a year-over-year increase of 4295.74%. This contributed to the annual value of -$14.2 million for FY2024, which is 6018.58% down from last year.
  • As of Q3 2025, Sunshine Biopharma's Free Cash Flow stood at -$735840.0, which was up 6072.55% from -$1.4 million recorded in Q2 2025.
  • Over the past 5 years, Sunshine Biopharma's Free Cash Flow peaked at -$297355.0 during Q1 2021, and registered a low of -$5.6 million during Q2 2024.
  • Its 5-year average for Free Cash Flow is -$1.8 million, with a median of -$1.4 million in 2025.
  • As far as peak fluctuations go, Sunshine Biopharma's Free Cash Flow crashed by 85815.88% in 2021, and later skyrocketed by 7418.31% in 2025.
  • Sunshine Biopharma's Free Cash Flow (Quarter) stood at -$312113.0 in 2021, then tumbled by 681.96% to -$2.4 million in 2022, then rose by 5.46% to -$2.3 million in 2023, then plummeted by 52.31% to -$3.5 million in 2024, then surged by 79.06% to -$735840.0 in 2025.
  • Its last three reported values are -$735840.0 in Q3 2025, -$1.4 million for Q2 2025, and -$1.7 million during Q1 2025.